[{"NetIncomeLoss_1_Q2_USD":-33535000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":2594446.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_2_Q2_USD":15.77,"ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination_2_Q2_USD":12838000.0,"Depreciation_2_Q2_USD":3129000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":320251000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_2_Q2_pure":0.017,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":5939000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":614116000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_2_Q2_pure":0.729,"AccruedLiabilitiesCurrent_0_Q2_USD":4832000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"InterestAndOtherIncome_1_Q2_USD":1893000.0,"InterestAndOtherIncome_2_Q2_USD":4787000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q2_USD":1699000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":2153000.0,"AssetsCurrent_0_Q2_USD":599521000.0,"OperatingLeaseExpense_2_Q2_USD":2300000.0,"OperatingLeaseExpense_1_Q2_USD":1200000.0,"ShareBasedCompensation_2_Q2_USD":11048000.0,"UnrealizedGainLossOnInvestments_2_Q2_USD":0.0,"Assets_0_Q2_USD":854822000.0,"CommonStockSharesIssued_0_Q2_shares":128233842.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":6596000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_2_Q2_USD":11215000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":6698000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":17024523.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":16954292.0,"SellingAndMarketingExpense_1_Q2_USD":14332000.0,"SellingAndMarketingExpense_2_Q2_USD":28339000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":4912000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":10255000.0,"ContractWithCustomerLiability_0_Q2_USD":263161000.0,"OtherNoncashIncomeExpense_2_Q2_USD":-49000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":126720986.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":37619000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":127383582.0,"GeneralAndAdministrativeExpense_2_Q2_USD":24059000.0,"CostsAndExpenses_2_Q2_USD":113427000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":11296000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_2_Q2_shares":88085.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":-1891000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q2_USD":57383000.0,"CommonStockValue_0_Q2_USD":12000.0,"CostsAndExpenses_1_Q2_USD":57897000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":-1481000.0,"AccountsReceivableNetCurrent_0_Q2_USD":7914000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":9244000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":59015000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":10.36,"ResearchAndDevelopmentExpense_1_Q2_USD":25992000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":49927000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":-1804000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_2_Q2_USD":433224000.0,"ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_0_Q2_shares":56875.0,"IncreaseDecreaseInInventories_2_Q2_USD":1467000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"IncreaseDecreaseInOtherOperatingCapitalNet_2_Q2_USD":215000.0,"OperatingLeaseLiability_0_Q2_USD":45732000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":-1160000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":1482000.0,"Liabilities_0_Q2_USD":324883000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":42503000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":365440000.0,"OtherAssetsNoncurrent_0_Q2_USD":1275000.0,"AmortizationOfIntangibleAssets_1_Q2_USD":423000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":847000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-34695000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-63456000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":-33535000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_2_Q2_USD":-64938000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":12238000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q2_shares":38174788.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_2_Q2_pure":0.71,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-62683000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_2_Q2_USD":0.16,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_2_Q2_shares":10000.0,"Goodwill_0_Q2_USD":118972000.0,"FinanceLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.046,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":6593000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":-1160000.0,"PaymentsForProceedsFromTenantAllowance_2_Q2_USD":-1300000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q2_USD":1699000.0,"ContractWithCustomerLiabilityRevenueRecognized_2_Q2_USD":-30003000.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":107747000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q2_USD":1699000.0,"RestrictedCashNoncurrent_0_Q2_USD":2138000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":1482000.0,"LiabilitiesCurrent_0_Q2_USD":93422000.0,"AccountsPayableCurrent_0_Q2_USD":3686000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":10691000.0,"NetIncomeLoss_2_Q2_USD":-64938000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":26833000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":1736000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_0_Q2_USD":3425000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent_0_Q2_USD":56405000.0,"OperatingLeasePayments_2_Q2_USD":900000.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":11081000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":2991200.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_2_Q2_pure":0.004,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":367578000.0,"AdditionalPaidInCapital_0_Q2_USD":958097000.0,"AreaOfLand_0_Q2_sqft":19867.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":11296000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_2_Q2_pure":0.705,"CommonStockSharesOutstanding_0_Q2_shares":128233842.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":-4746000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":268864000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-430323000.0,"PreferredStockValue_0_Q2_USD":null,"FiniteLivedIntangibleAssetsGross_0_Q2_USD":20325000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":29.95,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":75699000.0,"InventoryNet_0_Q2_USD":10536000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":204940000.0,"DebtSecuritiesAvailableForSaleAmortizedCostCurrent_0_Q2_USD":203765000.0,"OperatingIncomeLoss_1_Q2_USD":-36909000.0,"OperatingIncomeLoss_2_Q2_USD":-71529000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":20988000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":41898000.0,"CommonStockSharesAuthorized_0_Q2_shares":340000000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-4206000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":5956000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":12131000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":3.75,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":2952000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":854822000.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":16151815.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":651000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_0_Q2_USD":1703000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":5226000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":187462000.0,"StockholdersEquity_0_Q2_USD":529939000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":1496000.0,"ProfitLoss_2_Q2_USD":-64938000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.51,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.26,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q2_USD":856000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":3229000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q2_USD":70700000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":6373000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":11048000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":5976000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":-17165000.0,"Ticker":"ADPT","CIK":"1478320","name":"ADAPTIVE BIOTECHNOLOGIES CORP","OfficialName":"Adaptive Biotechnologies Corporation Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1463975665.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20200810"}]